+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Glycobiology Market, By Product (Enzymes, Instruments, Reagents and Kits), By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others), By End User, By Region, Competition, Forecast & Opportunities, 2025

  • ID: 5022640
  • Report
  • January 2021
  • Region: Global
  • 224 pages
  • TechSci Research

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Glycobiology Market Was Valued at USD 938.76 Million and is Expected to Grow at a Doubled Digit CAGR of 13.83% During the Forecast Period

FEATURED COMPANIES

  • Asparia Glycomics S.L.
  • Chemily Glycoscience
  • Glycotope GmbH
  • Merck & Co., Inc.
  • RayBiotech, Inc.
  • Thermo Fisher Scientific
The Global Glycobiology Market was valued at USD 938.76 Million and is expected to grow at a doubled digit CAGR of 13.83% during the forecast period.

The Global Glycobiology Market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines. This in turn has increased the drug discovery process around the globe, which is anticipated to positively impact growth of the market during the forecast period. Also, increasing grants by different governments especially in the developing nations for R&D activities is further expected to bolster the growth of the market over the next few years. Furthermore, increasing research activities in glycomics, technological advancements and rising government initiatives is also among the major drivers for the Global Glycobiology Market.

The Global Glycobiology Market is segmented based on product, application, End-user, company, and region. Based on product, the market can be categorized into enzymes, instruments, reagents, and kits. Among the following, enzymes contribute the majority of share in the market nearly about 35%.

Based on enzymes, they can be further bifurcated into glycosidases & neuramidases, glycosyltransferases & sialytransferases, carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases and others. The glycosidases & neuramidases segment is leading the market is expected to dominate the market during the forecast period as well. This can be ascribed to their pivotal role in metabolism, antibacterial defense & pathogenesis, glycosidase probe design for ABPP represents an important task in chemical proteomic & glycomic research.

Based on instruments, the market is fragmented into HPLC, mass spectrometry, MALDI-TOF, antibody arrays, lectin arrays, and others. The HPLC segment is attributed to dominate the market in the coming years. Based on reagents, the market is segmented into glycoproteins, oligosaccharides, monosaccharides, and others.

Based on kits, the glycobiology market is sub-segmented into glycan releasing kit, glycan purification kit, glycan labeling kit, and others.

Regionally, the glycobiology market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to witness significant growth during the forecast period in the overall glycobiology market owing to the presence of many research laboratories and pharmaceutical and biotechnology companies in the region.

Major players operating in the Global Glycobiology Market include Merck & Co., Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, New England Biolabs, Inc., Shimadzu Corporation, Takara Bio Inc., Waters Corporation, Asparia Glycomics S.L., Bruker Corporation, RayBiotech, Inc., Z Biotech, LLC., Chemily Glycoscience, Dextra Laboratories Ltd., Lectenz Bio, Ludger Ltd, R&D Systems, Inc., Glycotope GmbH, Danaher Corporation, S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Bio-Rad Laboratories and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments. For instance, in 2018, Shimadzu Corp. collaborated with premier Biosoft, a global company in the field of bioinformatics solutions, with an aim to introduce its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance glycomics and lipidomics data research analysis.

Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025

Objective of the Study:
  • To analyze and estimate the market size of the Global Glycobiology Market from 2015 to 2018.
  • To estimate and forecast the market size of the Global Glycobiology Market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast the Global Glycobiology Market based on type of enzyme, type of kit, application, End-user, company and regional distribution.
  • To identify dominant region or segment in the Global Glycobiology Market.
  • To identify drivers and challenges for the Global Glycobiology Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Glycobiology Market.
  • To identify and analyze the profile of leading players operating in the Global Glycobiology Market.
  • To identify key sustainable strategies adopted by market players in the Global Glycobiology Market.
The analyst performed both primary as well as exhaustive secondary research for this study. Initially, the analyst sourced a list of manufacturers of enzymes, kits & instruments used in glycobiology technique across the globe. Subsequently, the analyst conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the analyst could include the manufacturers of enzymes, kits & instruments used in glycobiology techniques which could not be identified due to the limitations of secondary research. The publisher analyzed the manufacturers of enzymes, kits & instruments used in glycobiology techniques, distribution channels and presence of all major players across the globe.

The analyst calculated the market size of the Global Glycobiology Market by using a bottom-up approach, wherein data for various End-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:
  • Glycobiology enzymes, kits & instruments, manufacturers, suppliers, distributorsand other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to glycobiology
Market Research and Consulting Firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers of enzymes, kits & instruments used in glycobiology techniques, suppliers and partners, End-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope

In this report, the Global Glycobiology Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Glycobiology Market, By Product:
  • Enzymes
  • Instruments
  • Reagents
  • Kits
Global Glycobiology Market, By Enzyme:
  • Glycosidases & Neuramidases
  • Glycosyltransferases & Sialytransferases
  • Carbohydrate Kinases
  • Carbohydrate Sulfotransferases
  • Protein Sulfotransferases
  • Others
Global Glycobiology Market, By Instruments:
  • HPLC
  • Antibody arrays
  • Lectin arrays
  • MALDI-TOF
  • Mass spectroscopy
  • Others
Global Glycobiology Market, By Kit:
  • Glycan Releasing Kit
  • Glycan Labelling Kit
  • Glycan Purification Kit
  • Others
Global Glycobiology Market, By Application:
  • Drug Discovery
  • Disease Diagnostics
  • Virology
  • Cell Biology
  • Oncology
  • Others
Global Glycobiology Market, By End-user:
  • Research Institutes
  • Diagnostic Centers
  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others
Global Glycobiology Market, By Region:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Glycobiology Market.

Available Customizations:

With the given market data, the analyst offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information
  • Detailed analysis and profiling of additional market players (up to five).

This report will be delivered within 3 business days and will include the latest impact analysis of COVID-19.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Asparia Glycomics S.L.
  • Chemily Glycoscience
  • Glycotope GmbH
  • Merck & Co., Inc.
  • RayBiotech, Inc.
  • Thermo Fisher Scientific
1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Glycobiology Market

4. Executive Summary

5. Voice of Customer
5.1. Brand Awareness
5.2. By Application
5.3. Factors driving the Glycobiology Market

6. Global Glycobiology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Enzymes, Instruments, Reagents and Kits)
6.2.1.1. By Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate Kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others)
6.2.1.2. By Instruments (HPLC, Antibody arrays, Lectin arrays, MALDI-TOF, Mass spectroscopy, Others)
6.2.1.3. By Reagents (Monosaccharides, Glycoproteins, Oligosaccharides, Others)
6.2.1.4. By Kits (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification Kit, Others)
6.2.2. By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others)
6.2.3. By End-user (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others)
6.2.4. By Company (2019)
6.2.5. By Region
6.3. Product Market Map

7. North America Glycobiology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.1.1. By Enzymes
7.2.1.2. By Instruments
7.2.1.3. By Reagents
7.2.1.4. By Kits
7.2.2. Application
7.2.3. By End-user
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Glycobiology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.1.1. By Enzymes
7.3.1.2.1.2. By Instruments
7.3.1.2.1.3. By Reagents
7.3.1.2.1.4. By Kits
7.3.1.2.2. By Application
7.3.1.2.3. By End-user
7.3.2. Canada Glycobiology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.1.1. By Enzymes
7.3.2.2.1.2. By Instruments
7.3.2.2.1.3. By Reagents
7.3.2.2.1.4. By Kits
7.3.2.2.2. By Application
7.3.2.2.3. By End-user
7.3.3. Mexico Glycobiology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.1.1. By Enzymes
7.3.3.2.1.2. By Instruments
7.3.3.2.1.3. By Reagents
7.3.3.2.1.4. By Kits
7.3.3.2.2. By Application
7.3.3.2.3. By End-user

8. Europe Glycobiology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.1.1. By Enzymes
8.2.1.2. By Instruments
8.2.1.3. By Reagents
8.2.1.4. By Kits
8.2.2. Application
8.2.3. By End-user
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Glycobiology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.1.1. By Enzymes
8.3.1.2.1.2. By Instruments
8.3.1.2.1.3. By Reagents
8.3.1.2.1.4. By Kits
8.3.1.2.2. By Application
8.3.1.2.3. By End-user
8.3.2. United Kingdom Glycobiology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.1.1. By Enzymes
8.3.2.2.1.2. By Instruments
8.3.2.2.1.3. By Reagents
8.3.2.2.1.4. By Kits
8.3.2.2.2. By Application
8.3.2.2.3. By End-user
8.3.3. France Glycobiology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.1.1. By Enzymes
8.3.3.2.1.2. By Instruments
8.3.3.2.1.3. By Reagents
8.3.3.2.1.4. By Kits
8.3.3.2.2. By Application
8.3.3.2.3. By End-user
8.3.4. Italy Glycobiology Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.1.1. By Enzymes
8.3.4.2.1.2. By Instruments
8.3.4.2.1.3. By Reagents
8.3.4.2.1.4. By Kits
8.3.4.2.2. By Application
8.3.4.2.3. By End-user
8.3.5. Spain Glycobiology Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.1.1. By Enzymes
8.3.5.2.1.2. By Instruments
8.3.5.2.1.3. By Reagents
8.3.5.2.1.4. By Kits
8.3.5.2.2. By Application
8.3.5.2.3. By End-user

9. Asia Pacific Glycobiology Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.3. Market Share & Forecast
9.3.1. By Product
9.3.1.1. By Enzymes
9.3.1.2. By Instruments
9.3.1.3. By Reagents
9.3.1.4. By Kits
9.3.2. Application
9.3.3. By End-user
9.3.4. By Country
9.4. Asia Pacific: Country Analysis
9.4.1. China Glycobiology Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Product
9.4.1.2.1.1. By Enzymes
9.4.1.2.1.2. By Instruments
9.4.1.2.1.3. By Reagents
9.4.1.2.1.4. By Kits
9.4.1.2.2. By Application
9.4.1.2.3. By End-user
9.4.2. Japan Glycobiology Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Product
9.4.2.2.1.1. By Enzymes
9.4.2.2.1.2. By Instruments
9.4.2.2.1.3. By Reagents
9.4.2.2.1.4. By Kits
9.4.2.2.2. By Application
9.4.2.2.3. By End-user
9.4.3. South Korea Glycobiology Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Product
9.4.3.2.1.1. By Enzymes
9.4.3.2.1.2. By Instruments
9.4.3.2.1.3. By Reagents
9.4.3.2.1.4. By Kits
9.4.3.2.2. By Application
9.4.3.2.3. By End-user
9.4.4. Australia Glycobiology Market Outlook
9.4.4.1. Market Size & Forecast
9.4.4.1.1. By Value
9.4.4.2. Market Share & Forecast
9.4.4.2.1. By Product
9.4.4.2.1.1. By Enzymes
9.4.4.2.1.2. By Instruments
9.4.4.2.1.3. By Reagents
9.4.4.2.1.4. By Kits
9.4.4.2.2. By Application
9.4.4.2.3. By End-user
9.4.5. India Glycobiology Market Outlook
9.4.5.1. Market Size & Forecast
9.4.5.1.1. By Value
9.4.5.2. Market Share & Forecast
9.4.5.2.1. By Product
9.4.5.2.1.1. By Enzymes
9.4.5.2.1.2. By Instruments
9.4.5.2.1.3. By Reagents
9.4.5.2.1.4. By Kits
9.4.5.2.2. By Application
9.4.5.2.3. By End-user

10. South America Glycobiology Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.1.1. By Enzymes
10.2.1.2. By Instruments
10.2.1.3. By Reagents
10.2.1.4. By Kits
10.2.2. Application
10.2.3. By End-user
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Glycobiology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.1.1. By Enzymes
10.3.1.2.1.2. By Instruments
10.3.1.2.1.3. By Reagents
10.3.1.2.1.4. By Kits
10.3.1.2.2. By Application
10.3.1.2.3. By End-user
10.3.2. Argentina Glycobiology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.1.1. By Enzymes
10.3.2.2.1.2. By Instruments
10.3.2.2.1.3. By Reagents
10.3.2.2.1.4. By Kits
10.3.2.2.2. By Application
10.3.2.2.3. By End-user
10.3.3. Colombia Glycobiology Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.1.1. By Enzymes
10.3.3.2.1.2. By Instruments
10.3.3.2.1.3. By Reagents
10.3.3.2.1.4. By Kits
10.3.3.2.2. By Application
10.3.3.2.3. By End-user

11. Middle East and Africa Glycobiology Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type of Enzyme
11.2.2. By Type of Kit
11.2.3. By Application
11.2.4. By End-user
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. UAE Glycobiology Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.1.1. By Enzymes
11.3.1.2.1.2. By Instruments
11.3.1.2.1.3. By Reagents
11.3.1.2.1.4. By Kits
11.3.1.2.2. By Application
11.3.1.2.3. By End-user
11.3.2. Saudi Arabia Glycobiology Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.1.1. By Enzymes
11.3.2.2.1.2. By Instruments
11.3.2.2.1.3. By Reagents
11.3.2.2.1.4. By Kits
11.3.2.2.2. By Application
11.3.2.2.3. By End-user
11.3.3. South Africa Glycobiology Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.1.1. By Enzymes
11.3.3.2.1.2. By Instruments
11.3.3.2.1.3. By Reagents
11.3.3.2.1.4. By Kits
11.3.3.2.2. By Application
11.3.3.2.3. By End-user
11.3.4. Kuwait Glycobiology Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product
11.3.4.2.1.1. By Enzymes
11.3.4.2.1.2. By Instruments
11.3.4.2.1.3. By Reagents
11.3.4.2.1.4. By Kits
11.3.4.2.2. By Application
11.3.4.2.3. By End-user

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape
14.1. Merck & Co., Inc.
14.2. Agilent Technologies, Inc.
14.3. Thermo Fisher Scientific
14.4. New England Biolabs, Inc.
14.5. Shimadzu Corporation
14.6. Takara Bio Inc.
14.7. Waters Corporation
14.8. Asparia Glycomics S.L.
14.9. Bruker Corporation
14.10. RayBiotech, Inc.
14.11. Z Biotech, LLC.
14.12. Chemily Glycoscience
14.13. Dextra Laboratories Ltd.
14.14. Lectenz Bio
14.15. Ludger Ltd
14.16. R&D Systems, Inc.
14.17. Glycotope GmbH
14.18. Danaher Corporation
14.19. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
14.20. Bio-Rad Laboratories

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures
Figure 1: Global Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 2: Global Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 3: Global Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 4: Global Glycobiology Market Shar, By Product, By Instruments, By Value, 2015-2025F
Figure 5: Global Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 6: Global Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 7: Global Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 8: Global Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 9: Global Glycobiology Market Share, By Company, By Value, 2019
Figure 10: Global Glycobiology Market Share, By Region, By Value, 2019 & 2025F
Figure 11: Global Glycobiology Market Map, By Product - Market Size (USD Million) & Growth Rate (%)
Figure 12: Global Glycobiology Market Map, By Application - Market Size (USD Million) & Growth Rate (%)
Figure 13: Global Glycobiology Market Map, By End-user - Market Size (USD Million) & Growth Rate (%)
Figure 14: Global Glycobiology Market Map, By Region - Market Size (USD Million) & Growth Rate (%)
Figure 15: North America Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 16: North America Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 17: North America Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 18: North America Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 19: North America Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 20: North America Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 21: North America Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 22: North America Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 23: North America Glycobiology Market Share, By Country, By Value, 2015-2025F
Figure 24: United States Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 25: New Cancer Cases in United States, (%), 2019
Figure 26: United States Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 27: United States Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 28: United States Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 29: United States Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 30: United States Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 31: United States Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 32: United States Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 33: Canada Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 34: Canada Hospital Establishments, By Region, 2019 (Units)
Figure 35: Canada Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 36: Canada Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 37: Canada Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 38: Canada Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 39: Canada Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 40: Canada Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 41: Canada Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 42: Mexico Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 43: Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
Figure 44: Mexico Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 45: Mexico Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 46: Mexico Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 47: Mexico Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 48: Mexico Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 49: Mexico Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 50: Mexico Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 51: Europe Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 52: Europe Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 53: Europe Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 54: Europe Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 55: Europe Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 56: Europe Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 57: Europe Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 58: Europe Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 59: Europe Glycobiology Market Share, By Country, By Value, 2015-2025F
Figure 60: Germany Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 61: Number of Employees in the German Bio and Laboratory Technologies Industry, (Thousand), 2015-2019
Figure 62: Germany Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 63: Germany Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 64: Germany Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 65: Germany Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 66: Germany Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 67: Germany Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 68: Germany Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 69: United Kingdom Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 70: Geriatric Population Numbers & Projections in United Kingdom (Millions), 2019
Figure 71: United Kingdom Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 72: United Kingdom Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 73: United Kingdom Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 74: United Kingdom Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 75: United Kingdom Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 76: United Kingdom Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 77: United Kingdom Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 78: France Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 79: France Healthcare Spending, By Value (USD Per Capita), 2015-2019
Figure 80: France Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 81: France Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 82: France Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 83: France Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 84: France Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 85: France Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 86: France Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 87: Italy Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 88: New Cancer Cases in Italy (%), Males, All Ages, 2019
Figure 89: Italy Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 90: Italy Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 91: Italy Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 92: Italy Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 93: Italy Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 94: Italy Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 95: Italy Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 96: Spain Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 97: Total Number of Hospitals in Spain, 2019
Figure 98: Spain Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 99: Spain Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 100: Spain Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 101: Spain Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 102: Spain Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 103: Spain Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 104: Spain Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 105: Asia Pacific Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 106: Asia Pacific Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 107: Asia Pacific Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 108: Asia Pacific Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 109: Asia Pacific Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 110: Asia Pacific Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 111: Asia Pacific Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 112: Asia Pacific Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 113: Asia-Pacific Glycobiology Market Share, By Country, By Value, 2015-2025F
Figure 114: China Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 115: New Cancer Cases in China (%), 2019
Figure 116: China Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 117: China Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 118: China Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 119: China Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 120: China Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 121: China Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 122: China Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 123: Japan Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 124: Japan Total Health Expenditure as a Share of GDP (%), 2015-2019
Figure 125: Japan Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 126: Japan Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 127: Japan Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 128: Japan Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 129: Japan Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 130: Japan Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 131: Japan Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 132: South Korea Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 133: New Cancer Cases in South Korea (%), 2019
Figure 134: South Korea Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 135: South Korea Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 136: South Korea Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 137: South Korea Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 138: South Korea Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 139: South Korea Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 140: South Korea Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 141: Australia Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 142: % of Public and Private Hospitals in Australia, 2019
Figure 143: Australia Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 144: Australia Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 145: Australia Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 146: Australia Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 147: Australia Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 148: Australia Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 149: Australia Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 150: India Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 151: Age Wise Prevalence of Breast Cancer in India, (%), Out of 100 Patients, 2019
Figure 152: India Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 153: India Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 154: India Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 155: India Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 156: India Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 157: India Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 158: India Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 159: South America Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 160: South America Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 161: South America Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 162: South America Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 163: South America Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 164: South America Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 165: South America Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 166: South America Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 167: South America Glycobiology Market Share, By Country, By Value, 2015-2025F
Figure 168: Brazil Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 169: Total Number of Hospitals in Brazil, 2015-2019
Figure 170: Brazil Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 171: Brazil Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 172: Brazil Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 173: Brazil Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 174: Brazil Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 175: Brazil Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 176: Brazil Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 177: Argentina Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 178: Argentina Health Expenditure (% of GDP), 2015-2019
Figure 179: Argentina Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 180: Argentina Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 181: Argentina Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 182: Argentina Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 183: Argentina Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 184: Argentina Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 185: Argentina Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 186: Colombia Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 187: % of Public and Private Hospitals in Colombia, 2019
Figure 188: Colombia Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 189: Colombia Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 190: Colombia Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 191: Colombia Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 192: Colombia Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 193: Colombia Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 194: Colombia Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 195: Middle East & Africa Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 196: Middle East & Africa Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 197: Middle East & Africa Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 198: Middle East & Africa Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 199: Middle East & Africa Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 200: Middle East & Africa Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 201: Middle East & Africa Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 202: Middle East & Africa Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 203: Middle East and Africa Glycobiology Market Share, By Country, By Value, 2015-2025F
Figure 204: UAE Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 205: UAE Health Expenditure (% of GDP), 2015-2019
Figure 206: UAE Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 207: UAE Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 208: UAE Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 209: UAE Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 210: UAE Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 211: UAE Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 212: UAE Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 213: Saudi Arabia Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 214: Total Number of Hospitals in Saudi Arabia, 2015-2019
Figure 215: Saudi Arabia Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 216: Saudi Arabia Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 217: Saudi Arabia Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 218: Saudi Arabia Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 219: Saudi Arabia Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 220: Saudi Arabia Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 221: Saudi Arabia Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 222: South Africa Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 223: South Africa Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
Figure 224: South Africa Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 225: South Africa Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 226: South Africa Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 227: South Africa Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 228: South Africa Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 229: South Africa Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 230: South Africa Glycobiology Market Share, By End-user, By Value, 2015-2025F
Figure 231: Kuwait Glycobiology Market Size, By Value, 2015-2025F (USD Million)
Figure 232: Kuwait Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
Figure 233: Kuwait Glycobiology Market Share, By Product, By Value, 2015-2025F
Figure 234: Kuwait Glycobiology Market Share, By Product, By Enzymes, By Value, 2015-2025F
Figure 235: Kuwait Glycobiology Market Share, By Product, By Instruments, By Value, 2015-2025F
Figure 236: Kuwait Glycobiology Market Share, By Product, By Reagents, By Value, 2015-2025F
Figure 237: Kuwait Glycobiology Market Share, By Product, By Kits, By Value, 2015-2025F
Figure 238: Kuwait Glycobiology Market Share, By Application, By Value, 2015-2025F
Figure 239: Kuwait Glycobiology Market Share, By End-user, By Value, 2015-2025F
Note: Product cover images may vary from those shown
  • Merck & Co., Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific
  • New England Biolabs, Inc.
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Waters Corporation
  • Asparia Glycomics S.L.
  • Bruker Corporation
  • RayBiotech, Inc.
  • Z Biotech, LLC.
  • Chemily Glycoscience
  • Dextra Laboratories Ltd.
  • Lectenz Bio
  • Ludger Ltd
  • R&D Systems, Inc.
  • Glycotope GmbH
  • Danaher Corporation
  • S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • Bio-Rad Laboratories
Note: Product cover images may vary from those shown
Adroll
adroll